Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
No serious adverse events, liver enzyme elevations, or cardiovascular changes were documented in the Phase 1 safety study published in the Journal of Clinical Endocrinology & Metabolism in 2024
Clinical trials showed that AOD-9604 has no effect on IGF-1 levels and does not interfere with glucose metabolism, making it compatible with various metabolic protocols
If you want to establish a Lipo B12 program in your clinic, contact National Medical Resources, Inc
Which one is better
The peptide stimulates lipolysis (fat breakdown) and inhibits lipogenesis (fat formation) without directly affecting muscle proteins
US$ 21.56
US$ 20.23
US$ 26.94
US$ 29.66
